載入...
CROI 2015: Highlights of Viral Hepatitis Therapy
High cure rates with all-oral regimens for patients with HIV/hepatitis C virus (HCV) coinfection were a highlight of the 2015 Conference on Retroviruses and Opportunistic Infections. Twelve weeks of sofosbuvir and daclatasvir led to sustained virologic response (SVR) rates of 96% in treatment-nave a...
Na minha lista:
| 發表在: | Top Antivir Med |
|---|---|
| Main Authors: | , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
IAS-USA
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6148900/ https://ncbi.nlm.nih.gov/pubmed/25965313 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|